MINERALYS THERAPEUTICS INC (MLYS) Stock Balance Sheet
USA - NASDAQ:MLYS - US6031701013 - Common Stock
40.85 USD
-3.44 (-7.77%)
40.75 USD
-0.1 (-0.24%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.01M | 664.00K | 643.00K | 87.70M | 10.61M | |||
| Cash Equivalents | 100.78M | 113.43M | 48.66M | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 223.13M | 84.10M | 187.26M | 22.41M | 0 | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 10.35M | 7.16M | 12.54M | 2.70M | 510.00K | |||
| Total Current Assets | 335.27M | 205.35M | 249.10M | 112.81M | 11.12M | |||
| Non-Current Assets | ||||||||
| PPE Net | 22.00K | 53.00K | null | null | null | |||
| Investments And Advances | null | 0 | 2.48M | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 433.00K | 499.00K | 51.00K | 1.63M | 3.00K | |||
| Total Non-Current Assets | 455.00K | 552.00K | 2.53M | 1.63M | 3.00K | |||
| TOTAL ASSETS | 335.72M | 205.90M | 251.64M | 114.44M | 11.13M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 19.01M | 14.17M | 9.88M | 6.16M | 4.29M | |||
| Accounts Payable | 3.16M | 479.00K | 601.00K | 1.91M | 763.00K | |||
| Other Current Liabilities | null | null | null | 649.00K | 342.00K | |||
| Total Current Liabilities | 22.17M | 14.65M | 10.48M | 8.07M | 5.05M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | null | null | |||
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | |||
| TOTAL LIABILITIES | 22.17M | 14.65M | 10.48M | 8.07M | 5.05M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -388.00M | -302.52M | -124.71M | -52.81M | -23.01M | |||
| Additional Paid In Capital | 701.55M | 493.77M | 365.86M | 540.00K | 85.00K | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 6.00K | 5.00K | 4.00K | 158.65M | 29.00M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 65.73M | 49.82M | 41.13M | 37.06M | 37.06M | |||
| Tangible Book Value per Share | 4.7706 | 3.8388 | 5.8627 | -1.4105 | -0.6186 | |||
| Total Shareholders' Equity | 313.55M | 191.26M | 241.15M | 106.38M | 6.07M | |||
| TOTAL LIABILITIES AND EQUITY | 335.72M | 205.90M | 251.64M | 114.44M | 11.13M | |||
| Statistics | ||||||||
| Current Ratio | 15.12 | 14.02 | 23.76 | 13.98 | 2.20 | |||
| Return On Assets (ROA) | -56.82% | -86.36% | -28.57% | -26.04% | -174.45% | |||
| Return On Equity (ROE) | -60.84% | -92.97% | -29.81% | -28.01% | -319.68% | |||
All data in USD , ROIC based on taxRate of 0.21